Ontology highlight
ABSTRACT: Introduction
Despite some recent advances in treatment options, pancreatic cancer remains a devastating disease with poor outcomes. In a trend contrary to most malignancies, both incidence and mortality continue to rise due to pancreatic cancer. The majority of patients present with advanced disease and there are no treatment options for this stage that have demonstrated a median survival > 1 year. As the penultimate step prior to Phase III studies involving hundreds of patients, Phase II clinical trials provide an early opportunity to evaluate the efficacy of new treatments that are desperately needed for this disease.Areas covered
This review covers the results of published Phase II clinical trials in advanced pancreatic adenocarcinoma published within the past 5 years. T
SUBMITTER: Kim EJ
PROVIDER: S-EPMC4684166 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature